"Lunatum Biotech’s expertise in musculoskeletal research, particularly in osteoarthritis, has been invaluable to us. Their use of advanced models and innovative approaches—integrating behavioral studies, imaging, and post-mortem analyses—delivers unparalleled insights into treatment efficacy. Their precision, scientific rigor, and transparency make them a trusted partner in advancing our projects. The Lunatum team was always mindful of our budget and consistently available for questions or updates."
Mari Anne Snow, CEO of
EASCRA BIOTECH, Inc.,
MassBioDrive Startup of the Year,
NASA and ISS National Lab
sponsored research on the ISS
Lunatum Biotech is your preclinical CRO orthopedics and your trusted partner in musculoskeletal drug discovery, specializing in preclinical development for joint, cartilage, bone, tendon, and muscle diseases. With decades of expertise and a focus on innovation, we help navigate the complexities of rare and common musculoskeletal disorders to develop impactful therapies.
For molecular therapy and gene delivery system developers, the growing field of musculoskeletal medicine offers vast opportunities. Our preclinical CRO expert team, each with 20+ years in orthopedic research, collaborates with you to identify high-impact disease indications and drive breakthroughs in treatment. Together, let's transform patient care and shape the future of medicine. We have a special focus on CRO osteoarthritis services and CRO bone services.